Dosing Regimens Before and During Long-Term Treatment with Recombinant Factor VIII FC Fusion Protein (rFVIIIFc) in Children with Severe Haemophilia A: An Updated Analysis of the ASPIRE Study

被引:0
|
作者
Nolan, B. [1 ]
Young, G. [2 ]
Mahlangu, J. N. [3 ,4 ]
Liesner, R. [5 ]
Pasi, K. J. [6 ]
Yuan, H. [7 ]
Winding, B. [8 ]
Ramirez-Santiago, A. [7 ]
Dumont, J. [7 ]
Lethagen, S. [8 ,9 ]
Glazebrook, D. V. [7 ]
机构
[1] Our Ladys Childrens Hosp, Dublin, Ireland
[2] Univ Southern Calif, Keck Sch Med, Childrens Hosp Los Angeles, Los Angeles, CA USA
[3] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa
[4] Univ Witwatersrand, Natl Hlth Lab Serv, Johannesburg, South Africa
[5] Great Ormond St Hosp Sick Children, London, England
[6] Barts & London Comprehens Care Ctr, London, England
[7] Biogen, Cambridge, MA USA
[8] Sobi, Stockholm, Sweden
[9] Univ Copenhagen, Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P023
引用
收藏
页码:42 / 43
页数:2
相关论文
共 50 条
  • [21] Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia A
    Shapiro, A. D.
    Mahlangu, J. N.
    Perry, D.
    Pasi, J.
    Quon, D. V.
    Chowdary, P.
    Tsao, E.
    Li, S.
    Innes, A.
    Pierce, G. F.
    Allen, G. A.
    HAEMOPHILIA, 2017, 23 (03) : 392 - 399
  • [22] Dosing intervals and bleeding rates before and following treatment with recombinant factor VIII Fc fusion protein in patients with severe haemophilia A: experience from the A-LONG clinical study
    Oldenburg, J.
    Shapiro, A.
    Ragni, M. V.
    Kulkarni, R.
    Kulke, S.
    Potts, J.
    Neelakantan, S.
    Nestorov, I.
    Dumont, J. A.
    Jiang, H.
    Brennan, A.
    Pierce, G. F.
    HAEMOPHILIA, 2014, 20 : 60 - 61
  • [23] Treatment of bleeding episodes in subjects with haemophilia A with long-lasting recombinant Factor VIII Fc fusion protein (rFVIIIFc) in the Phase 3 A-LONG study
    Ragni, M.
    Josephson, N.
    Mahlangu, J.
    Pasi, J.
    Perry, D.
    Powell, J.
    Shapiro, A. D.
    Krassova, S.
    Greblikas, F.
    Nugent, K.
    Brennan, A.
    Luk, A.
    Pierce, G. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 928 - 929
  • [24] Recombinant Fusion Factor VIII-Fc Fusion Protein in Severe Haemophilia A Patients
    Le Quellec, Sandra
    HEMATOLOGIE, 2014, 20 (06): : 304 - 306
  • [25] Modified Haemophilia Joint Health Scores (MHJHS) Outcomes with Recombinant Factor VIII FC Fusion Protein (rFVIIIFc) Prophylaxis in Subjects with Severe Haemophilia A
    Oldenburg, J.
    Srivastava, A.
    Mahlangu, J.
    Blanchette, V.
    Kulkarni, R.
    Li, S.
    Tsao, E.
    Jain, N.
    HAEMOPHILIA, 2016, 22 : 68 - 69
  • [26] Improvements in joint health during long-term use of recombinant factor VIII Fc fusion protein prophylaxis in subjects with haemophilia A
    Oldenburg, J.
    Pasi, J.
    Pabinger, I.
    Nolan, B.
    Kulkarni, R.
    Blanchette, V.
    Tripkovic, N.
    Feng, J.
    Jain, N.
    HAEMOPHILIA, 2019, 25 : 114 - 114
  • [27] Safety, Efficacy, and Pharmacokinetics of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) in Previously Treated Paediatric Subjects with Severe Haemophilia A (Kids A-LONG)
    Young, G.
    Mahlangu, J.
    Kulkarni, R.
    Nolan, B.
    Liesner, R.
    Pasi, J.
    Barnes, C.
    Neelakantan, S.
    Gambino, G.
    Cristiano, L. M.
    Pierce, G. F.
    Allen, G.
    HAEMOPHILIA, 2015, 21 : 32 - 32
  • [28] THE CLINICAL AND ECONOMIC IMPACT OF RECOMBINANT FACTOR VIII FC FUSION PROTEIN (RFVIIIFC) ON LONG-TERM JOINT HEALTH IN PEOPLE WITH HEMOPHILIA A (PWHA)
    Batt, K.
    Cockerham, A.
    Sacks, N.
    Jin, H.
    Nguyen, A. T. H.
    HAEMOPHILIA, 2022, 28 : 93 - 94
  • [29] Long-lasting recombinant factor VIII Fc fusion (rFVIIIFc) for perioperative management of subjects with haemophilia A in the phase 3 A-LONG study
    Mahlangu, J.
    Powell, J.
    Josephson, N.
    Klamroth, R.
    Parra Lopez, R.
    Morfini, M.
    Oldenburg, J.
    Pasi, J.
    Perry, D.
    Ragni, M.
    Shapiro, A. D.
    Dunkley, S.
    Apte, S.
    Krassova, S.
    Greblikas, F.
    Innes, A.
    Nugent, K.
    Brennan, A.
    Luk, A.
    Pierce, G. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 459 - 459
  • [30] Long-Term Efficacy and Quality of Life with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Prophylaxis in Pediatric, Adolescent, and Adult Subjects with Target Joints and Severe Hemophilia a
    Wang, Michael
    Pasi, K. John
    Pabinger, Ingrid
    Kerlin, Bryce A.
    Kulkarni, Roshni
    Nolan, Beatrice
    Liesner, Raina
    Brown, Simon A.
    Hanabusa, Hideji
    Tsao, Elisa
    Winding, Bent
    Lethagen, Stefan
    Jain, Nisha
    BLOOD, 2016, 128 (22)